Seijun Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.06 M
- Revenue Growth 128.47%
- Profit Growth 153.54%
- Ebitda 179.54%
- Net Worth 108.28%
- Total Assets 104.67%
About Seijun Pharmaceuticals
Seijun Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 May 2020 (Four years and eight months 11 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.06 M.
Suneetha Ponduri and Sivasankara Reddy serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397TG2020PTC140414
-
Company No.
140414
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 May 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Seijun Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suneetha Ponduri
|
Director | 23-May-2020 | Current |
|
Sivasankara Reddy
|
Director | 23-May-2020 | Current |
Financial Performance of Seijun Pharmaceuticals.
Seijun Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 128.47% increase. The company also saw a substantial improvement in profitability, with a 153.54% increase in profit. The company's net worth Soared by an impressive increase of 108.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Seijun Pharmaceuticals?
Unlock access to Seijun Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Spacetronics Solutions Private LimitedSuneetha Ponduri is a mutual person
-
Datatron Technologies Private Limited
Suneetha Ponduri is a mutual person
-
Ameeba Logistics Private Limited
Suneetha Ponduri is a mutual person
-
Americares Foundation
Suneetha Ponduri is a mutual person
Charges (Loans)
₹1.06 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Dec 2022 | Hdfc Bank Limited | ₹1.06 M | Open |
How Many Employees Work at Seijun Pharmaceuticals?
Seijun Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seijun Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seijun Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.